
OraSure Technologies OSUR
€ 2.53
-1.17%
Geschäftsbericht 2025
hinzugefügt 09.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NASDAQ GLOBALSPB |
Anteile |
73.5 M |
Marktkapitalisierung |
$ 218 M |
EBITDA (LTM) |
$ -47 M |
P/E (LTM) |
-4.17 |
P/S (LTM) |
1.72 |
EPS (LTM) |
-0.72 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 126.93 | 3.74 % | $ 4.06 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 76.13 | 0.46 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.93 | -0.55 % | $ 26.5 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 64.3 | -0.19 % | $ 12.8 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.03 | 1.77 % | $ 186 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.17 | -1.36 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.32 | 1.15 % | $ 26.3 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 60.81 | 1.38 % | $ 3.06 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.07 | -1.7 % | $ 51.5 K | Nasdaq Global Select Market | ||
|
ICU Medical
ICUI
|
$ 122.32 | -2.0 % | $ 3.01 B | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.79 | - | $ 4.5 B | NYSE | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 471.29 | -2.27 % | $ 168 B | Nasdaq Global Select Market,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 121.88 | 0.18 % | $ 5.9 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 221.92 | 0.08 % | $ 21.9 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 136.38 | -0.13 % | $ 6.09 B | NYSE,SPB | ||
|
Masimo Corporation
MASI
|
$ 178.6 | -0.02 % | $ 9.52 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.6 | 2.71 % | $ 219 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 67.27 | -1.91 % | $ 3.98 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.07 | -0.15 % | $ 217 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 301.01 | -1.6 % | $ 21.8 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 22.39 | -2.74 % | $ 1.51 B | Nasdaq Global Select Market | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.9 | -0.13 % | $ 2.37 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.63 | -1.72 % | $ 18.9 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 51.94 | -0.32 % | $ 171 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 115.31 | 1.64 % | $ 2.61 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
STAAR Surgical Company
STAA
|
$ 26.2 | 2.06 % | $ 1.3 B | Nasdaq Global Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 21.31 | -0.33 % | $ 982 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.94 | 0.26 % | $ 176 M | NYSE American | ||
|
Baxter International
BAX
|
$ 18.46 | 1.68 % | $ 9.47 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 222.96 | 1.47 % | $ 32.6 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 29.06 | -0.75 % | $ 1.39 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.56 | -4.37 % | $ 291 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.01 | -0.81 % | $ 450 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 150.72 | -0.92 % | $ 43.4 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.99 | 4.3 % | $ 31.1 M | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 118.39 | 0.67 % | $ 6.6 M | Nasdaq Global Select Market,SPB |